SEOUL-VIOSYS
Seoul Viosys (KOSDAQ:092190), a leading compound semiconductor solution provider, announced that it promotes new Violeds technology solution, the world’s first ultraviolet LED technology proven to sterilize new coronaviruses, for air conditioning and heating systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200820005452/en/
Seoul Viosys will hold a campaign of pilot installation for new Violeds technology solution by August 31st , 2020 focusing on public facilities such as offices, shopping centers, and airport in the world as a part of anti-coronavirus. Inquiries and applications are available on its website (www.seoulviosys.com/en/ ) and Seoul Viosys’ partners will support additional requests after finishing the first campaign period.
Seoul Viosys provides major manufacturer of air conditioners with optimized UV LED solutions based on successful testing results of 99.9% sterilization of the new coronavirus in 30 seconds by the research group of Korea University. In June, a global air conditioner manufacturer that produces 40 million per year has adopted Violeds technology for its thirty models.
Through the results of testing by Guangzhou Institute of Microbiology in China (CGMT), Gree demonstrates that its new “Fresh Air” air conditioner with Violeds UV LED technology has the performance to sterilize 99.15% of viruses and bacteria, 98% of enteroviruses such as EV71 and H1N1, and 99% of staphylococcus albus bacteria. In addition, it has been proven to sterilize 90% of various harmful viruses in air in 2 hours when using their air conditioners.
Violeds technology has been adopted not only by the Chinese AC manufacturer Gree, but also by a leading in-duct air treatment supplier in the U.S. Seoul Viosys will provide its technology for air conditioners of a leading electronics brand.
Conventional air conditioners typically draw outside air into the AC unit, and discharge that air back into the interior after cooling and filtering, where it is continuously recirculated. This recirculation of indoor air may cause a higher risk of infection through aerosol transmission when viruses are present. The amount of dust and moisture on the cooling filter can also transmit harmful viruses. Conventional filter in air purification system can filter out general droplets or fine dust more than 0.3μm but the viruses such as new coronavirus and SARS virus itself as small as 0.1μm can pass through the HEPA filters as it is.
“As a result of successful production approval to supply Violeds products and expanding customer demand, Violeds UV LEDs have clearly been recognized as essential technology for HVAC (Heating, Ventilation, and Air Conditioning) systems. We believe that our new Violeds technology solution for disinfection of air conditioning and heating systems helps to eliminate viruses in air and protect people from COVID-19 pandemic,” said a representative of Seoul Viosys.
About Seoul Viosys
Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and a single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured No. 1 market share in the UV LED industry (LEDinside, 2018). Seoul Viosys has an extensive UV LED portfolio with all wavelengths ranging from 200nm to 1600nm, including ultraviolet rays (UV), visible rays, and infrared rays. The company holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for robust sterilization and disinfection (UV-C), skin regeneration (UV-B), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add advanced VCSEL technology, which supports smartphone facial recognition and autonomous driving, and has started mass production. In January 2020, it introduced a disruptive “Micro Clean Pixel” that has the potential to be a game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200820005452/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 202512.11.2025 15:30:00 CET | Press release
– Multiple presentations on vimseltinib for the treatment of Tenosynovial Giant Cell Tumor (TGCT), including encore data from the Phase 3 MOTION study presented in an oral session – – Two posters on DCC-3009 in Gastrointestinal Stromal Tumor (GIST) – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that data from multiple pipeline programs, including long-term and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option, will be presented during the CTOS Annual Meeting 2025, taking place November 12-15 in Boca Raton, Florida. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112742665/en/ “We are excited about the breadth of data we’re presenting at CTOS this year, which underscore the strong progress we continue to sustain across our pipeline,” said Matthew L. Sherman, M.D
Deskpro Launches New Private Help Desk Solution with Private AI Support for Organizations with Strict Security, Compliance, and Data Sovereignty Requirements12.11.2025 15:13:00 CET | Press release
Deskpro Private Eliminates Impossible Choice Between AI Capabilities and Data Security for Organizations Including Financial Services, Healthcare, Aerospace and Defense, and Government Today, Deskpro, provider of the secure AI-powered help desk platform, announced the launch of Deskpro Private, making AI-powered help desk capabilities available to industries with stringent security and compliance requirements for the first time. The new platform delivers flexible private deployment, allowing companies to run their AI-powered help desk entirely within their AWS Virtual Private Cloud (VPC), on-premise enterprise data center, or sovereign cloud. Enterprises can connect to their AI of choice, including commercial, public, private, custom, and open source models, using existing organizational accounts and APIs. This means sensitive data never leaves the organization’s approved security perimeter. With Deskpro, organizations no longer need to sacrifice the measurable ROI from AI capabilities
New Study Reveals Tech Industry Leads AI Adoption in Support Operations at 92%; Regulated Industries Only at 58% Due to Compliance Constraints12.11.2025 15:06:00 CET | Press release
Research Finds Security and Compliance Requirements Are Reshaping Technology Adoption, with Healthcare, Finance, and Government Organizations Facing Deployment Constraints that Technology Companies Avoid Today, Deskpro, provider of the secure AI-powered help desk platform, released results from the State of AI in Support Operations: Balancing Innovation and Compliance report, which quantifies how security and compliance requirements are creating distinct market segments with vastly different AI adoption rates. According to the data, 92% of technology companies are adopting AI for support operations, while companies in regulated industries are significantly lagging behind with a 58% adoption rate. This 34-point gap reflects a significant disconnect: organizations are eager to adopt AI-powered support solutions, but face significant barriers related to data security, compliance and regulatory requirements, and deployment flexibility. While market demand for AI support capabilities exists
Ran Kurup Joins MinIO to Accelerate Corporate Strategic Growth12.11.2025 15:00:00 CET | Press release
MinIO, the data foundation for Enterprise AI, today announced the appointment of Ran Kurup as Chief Corporate Development Officer. In this newly created role, Kurup will lead MinIO’s global strategic growth initiatives, including geographic expansion, mergers and acquisitions, and other investment strategies designed to extend the company’s leadership in enterprise AI data infrastructure. Kurup joins MinIO from Intel Capital, where he played a central role in supporting high-growth companies across AI, data infrastructure, and enterprise technology. His extensive experience in driving operational scale for a wide range and quantity of investments positions him to advance MinIO’s long-term growth objectives. “Ran’s appointment underscores MinIO’s commitment to executing a disciplined and expansive growth strategy,” said Garima Kapoor, Co-founder and Co-CEO of MinIO. “As we continue to scale globally, his experience at the intersection of technology investment and enterprise transformati
InterSystems Launches HealthShare AI Assistant to Optimize Data Retrieval and Clinical Engagement with Conversational Intelligence12.11.2025 15:00:00 CET | Press release
New capability empowers clinicians with faster, safer access to unified patient data InterSystems, a creative data technology provider powering more than 1 billion health records worldwide, today announced the launch of InterSystems HealthShare AI Assistant, a new generative AI capability designed to assist clinicians, case managers, and administrators in accessing and understanding patient information faster and more intuitively. Built on the trusted foundation of InterSystems HealthShare Unified Care Record (UCR), HealthShare AI Assistant introduces a conversational interface that enables users to securely query, summarize, and navigate complex longitudinal health records using natural language prompts. The AI Assistant queries records from thousands of diverse clinical data sources and leverages Generative AI to surface relevant insights and present information using industry-standard displays—empowering users with faster, more intuitive access to comprehensive patient data and key
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom